359 related articles for article (PubMed ID: 25685956)
1. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis.
Chen J; Zhang WJ; Guo Z; Wang HB; Wang DD; Zhou JJ; Chen QW
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5373-83. PubMed ID: 25685956
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
3. Manganese-loaded dual-mesoporous silica spheres for efficient T1- and T2-weighted dual mode magnetic resonance imaging.
Niu D; Luo X; Li Y; Liu X; Wang X; Shi J
ACS Appl Mater Interfaces; 2013 Oct; 5(20):9942-8. PubMed ID: 24059807
[TBL] [Abstract][Full Text] [Related]
4. pH-Activatable MnO-Based Fluorescence and Magnetic Resonance Bimodal Nanoprobe for Cancer Imaging.
Hsu BY; Ng M; Tan A; Connell J; Roberts T; Lythgoe M; Zhang Y; Wong SY; Bhakoo K; Seifalian AM; Li X; Wang J
Adv Healthc Mater; 2016 Mar; 5(6):721-9. PubMed ID: 26895111
[TBL] [Abstract][Full Text] [Related]
5.
Li X; Zhou H; Niu Z; Zheng K; Niu D; Zhao W; Liu X; Si W; Li C; Wang P; Cao J; Li Y; Wen G
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24644-24654. PubMed ID: 32407072
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-PEG-modified Fe
Zhu H; Zhang L; Liu Y; Zhou Y; Wang K; Xie X; Song L; Wang D; Han C; Chen Q
Sci Rep; 2016 Dec; 6():39245. PubMed ID: 27976736
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents.
Huang X; Yuan Y; Ruan W; Liu L; Liu M; Chen S; Zhou X
J Nanobiotechnology; 2018 Mar; 16(1):30. PubMed ID: 29587764
[TBL] [Abstract][Full Text] [Related]
8. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
9. Intrinsically Mn2+-Chelated Polydopamine Nanoparticles for Simultaneous Magnetic Resonance Imaging and Photothermal Ablation of Cancer Cells.
Miao ZH; Wang H; Yang H; Li ZL; Zhen L; Xu CY
ACS Appl Mater Interfaces; 2015 Aug; 7(31):16946-52. PubMed ID: 26196160
[TBL] [Abstract][Full Text] [Related]
10. Manganese-Based Layered Double Hydroxide Nanoparticles as a T
Li B; Gu Z; Kurniawan N; Chen W; Xu ZP
Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28585312
[TBL] [Abstract][Full Text] [Related]
11. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
[TBL] [Abstract][Full Text] [Related]
12. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
[TBL] [Abstract][Full Text] [Related]
13. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging.
Hao Y; Zheng C; Wang L; Zhang J; Niu X; Song Q; Feng Q; Zhao H; Li L; Zhang H; Zhang Z; Zhang Y
Acta Biomater; 2017 Oct; 62():293-305. PubMed ID: 28842332
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent oligo(p-phenyleneethynylene) contained amphiphiles-encapsulated magnetic nanoparticles for targeted magnetic resonance and two-photon optical imaging in vitro and in vivo.
Yin C; Hong B; Gong Z; Zhao H; Hu W; Lu X; Li J; Li X; Yang Z; Fan Q; Yao Y; Huang W
Nanoscale; 2015 May; 7(19):8907-19. PubMed ID: 25916546
[TBL] [Abstract][Full Text] [Related]
15. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
[TBL] [Abstract][Full Text] [Related]
16. Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo.
Chen J; Zhang W; Zhang M; Guo Z; Wang H; He M; Xu P; Zhou J; Liu Z; Chen Q
Nanoscale; 2015 Aug; 7(29):12542-51. PubMed ID: 26140326
[TBL] [Abstract][Full Text] [Related]
17. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
19. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
